SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-059045
Filing Date
2023-07-24
Accepted
2023-07-24 09:05:08
Documents
14
Period of Report
2023-07-24
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea182223-8k_avalon.htm   iXBRL 8-K 26237
2 PRESS RELEASE ISSUED BY AVALON GLOBOCARE CORP., DATED JULY 24, 2023 ea182223ex99-1_avalon.htm EX-99.1 7891
3 GRAPHIC ex99-1_001.jpg GRAPHIC 11474
  Complete submission text file 0001213900-23-059045.txt   226965

Data Files

Seq Description Document Type Size
4 XBRL LABEL FILE albt-20230724_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE albt-20230724_pre.xml EX-101.PRE 22375
6 XBRL SCHEMA FILE albt-20230724.xsd EX-101.SCH 3039
8 EXTRACTED XBRL INSTANCE DOCUMENT ea182223-8k_avalon_htm.xml XML 3316
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 231103873
SIC: 2836 Biological Products, (No Diagnostic Substances)